Annexon (ANNX) Change in Account Payables (2019 - 2026)
Annexon (ANNX) posted quarterly Change in Account Payables of $2.2 million for Q1 2026, up 7038.71% year-over-year from $30131.5 in Q1 2025, and up 165.88% quarter-over-quarter from -$3.3 million in Q4 2025.
Analysis
Annexon (ANNX) Change in Account Payables (2019 - 2026) Analysis & Trends
Annexon's Change in Account Payables history runs 8 years deep, the most recent figure standing at $2.2 million for Q1 2026.
- In Q1 2026, Change in Account Payables rose 7038.71% year-over-year to $2.2 million; the TTM figure through Mar 2026 stood at $6.7 million (up 3.68% YoY), while the FY2025 annual figure was $4.5 million, down 9.02% from the prior year.
- Change in Account Payables for Q1 2026 stood at $2.2 million, up from -$3.3 million in the prior quarter.
- The five-year high for Change in Account Payables was $6.7 million in Q3 2025, with the low at -$3.4 million in Q3 2022.
- The 5-year median for Change in Account Payables is $490000.0 (2022), against an average of $542000.0.
- The sharpest annual moves came in 2022 and 2026: Change in Account Payables tumbled 514.18% in 2022, then soared 7038.71% in 2026.
- Annexon's Change in Account Payables stood at $490000.0 in 2022, then slipped by 13.06% to $426000.0 in 2023, then jumped by 765.96% to $3.7 million in 2024, then plunged by 188.51% to -$3.3 million in 2025, then jumped by 165.88% to $2.2 million in 2026.
- Business Quant data shows ANNX's Change in Account Payables at $2.2 million in Q1 2026, -$3.3 million in Q4 2025, and $6.7 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.77 Bn | 130.92 Bn | 2.84 Bn | -66.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.51 Bn | 77.52 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.20 Bn | 53.06 Bn | 52.00 Mn | -8.00 Mn |
| 5 | Revolution Medicines | 44.04 Bn | 44.04 Bn | - | 5.03 Mn |
| 6 | BeOne Medicines | 39.99 Bn | 34.89 Bn | 1.53 Bn | 37.53 Mn |
| 7 | Alnylam Pharmaceuticals | 35.45 Bn | 32.14 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.40 Bn | 27.56 Bn | - | - |
| 9 | Insmed | 27.44 Bn | 26.28 Bn | 358.27 Mn | - |
| 10 | Annexon | 977.88 Mn | 977.88 Mn | - | -1.36 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1.36 Mn |
| Mar 31, 2026 | 2.15 Mn |
| Dec 31, 2025 | -3.27 Mn |
| Sep 30, 2025 | 6.67 Mn |
| Jun 30, 2025 | 1.12 Mn |
| Mar 31, 2025 | -31,000.00 |
| Dec 31, 2024 | 3.69 Mn |
| Sep 30, 2024 | 2.70 Mn |
| Jun 30, 2024 | 74,000.00 |
| Mar 31, 2024 | -1.53 Mn |
| Dec 31, 2023 | 426,000.00 |
| Sep 30, 2023 | -2.35 Mn |
| Jun 30, 2023 | -3.19 Mn |
| Mar 31, 2023 | 3.04 Mn |
| Dec 31, 2022 | 490,000.00 |
| Sep 30, 2022 | -3.45 Mn |
| Jun 30, 2022 | 884,000.00 |
| Mar 31, 2022 | 1.79 Mn |
| Dec 31, 2021 | 2.99 Mn |
| Sep 30, 2021 | 832,000.00 |